Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Drugs Dermatol ; 16(2): 140-144, 2017 Feb 01.
Article in English | MEDLINE | ID: mdl-28300856

ABSTRACT

BACKGROUND: This study measured skin hydration and occlusivity of two test products [halobetasol propionate lotion, 0.05% (HBP Lotion) and Ultravate® (halobetasol propionate) cream, 0.05% (HBP Cream)] at 2, 4, and 6 hours after application to skin test sites previously challenged by dry shaving, which was performed to compromise the integrity of the stratum corneum barrier. METHODS: Trans-epidermal water loss (TEWL), an indicator of skin barrier function, was measured using cyberDERM, inc. RG-1 evaporimeter. Skin hydration was evaluated using IBS SkiCon-200 conductance meter. Test products were applied bilaterally on dry-shaved sites on the volar forearm sites, according to a randomization scheme, with two test sites untreated to serve as "dry-shaved" controls. TEWL and conductance were measured at 2, 4, and 6 hours post-treatment. RESULTS: HBP Lotion displayed a significant increase in skin hydration at 2, 4, and 6 hours post-treatment compared to the baseline values and dry-shaved controls (each, P less than 0.001). However, HBP Cream produced statistically significant increased skin hydration only after 6 hours (P less than 0.05). HBP Lotion was significantly more effective than HBP Cream in increasing skin hydration at 2 and 4 hours post-treatment (each, P less than 0.001), and had a directional advantage (not statistically significant) at 6 hours. Neither test product had a significant occlusive effect as measured by TEWL at 2, 4, and 6 hours post-application. CONCLUSION: Both formulations of HBP (Lotion and Cream) contributed to skin moisturization, as measured by skin conductance. HBP Lotion produced a significantly more rapid onset and higher level of moisturization at 2 and 4 hours post-application compared to HBP Cream. The TEWL results indicate that neither HBP Lotion nor HBP Cream provided any significant occlusivity to the skin.

J Drugs Dermatol. 2017;16(2):140-144.

.


Subject(s)
Clobetasol/analogs & derivatives , Dermatitis, Atopic/drug therapy , Dermatologic Agents/therapeutic use , Administration, Cutaneous , Adult , Clobetasol/administration & dosage , Clobetasol/pharmacology , Clobetasol/therapeutic use , Dermatitis, Atopic/pathology , Dermatologic Agents/administration & dosage , Dermatologic Agents/pharmacology , Double-Blind Method , Drug Compounding , Emollients/administration & dosage , Emollients/pharmacology , Emollients/therapeutic use , Female , Forearm , Humans , Male , Middle Aged , Skin Cream , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/pharmacology , Vasoconstrictor Agents/therapeutic use , Water Loss, Insensible/drug effects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...